Literature DB >> 20177009

Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture.

Bruce M Psaty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20177009      PMCID： PMC2831994          DOI： 10.1161/CIRCULATIONAHA.109.933705

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  47 in total

Review 1.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

2.  Rosiglitazone monotherapy is effective in patients with type 2 diabetes.

Authors:  H E Lebovitz; J F Dole; R Patwardhan; E B Rappaport; M I Freed
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

5.  Strategy of prevention: lessons from cardiovascular disease.

Authors:  G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

6.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

7.  Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.

Authors:  Philip Greenland; Laurie LaBree; Stanley P Azen; Terence M Doherty; Robert C Detrano
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

8.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

10.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272
View more
  3 in total

1.  Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.

Authors:  Elisabetta Poluzzi; Carlo Piccinni; Paolo Carta; Aurora Puccini; Monica Lanzoni; Domenico Motola; Alberto Vaccheri; Fabrizio De Ponti; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2010-12-09       Impact factor: 2.953

2.  The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.

Authors:  Dov Shiffman; Ellen S O'Meara; Charles M Rowland; Judy Z Louie; Mary Cushman; Russell P Tracy; James J Devlin; Bruce M Psaty
Journal:  BMC Cardiovasc Disord       Date:  2011-03-15       Impact factor: 2.298

3.  Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

Authors:  Christopher J Miller; Jason V Baker; Alison M Bormann; Kristine M Erlandson; Katherine Huppler Hullsiek; Amy C Justice; Jacqueline Neuhaus; Roger Paredes; Kathy Petoumenos; Deborah Wentworth; Alan Winston; Julian Wolfson; James D Neaton
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.